131 related articles for article (PubMed ID: 8070311)
1. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
Marino MT; Peggins JO; Brown LD; Urquhart MR; Brewer TG
Drug Metab Dispos; 1994; 22(3):358-66. PubMed ID: 8070311
[TBL] [Abstract][Full Text] [Related]
2. An improved pharmacodynamic model for formation of methemoglobin by antimalarial drugs.
Fasanmade AA; Jusko WJ
Drug Metab Dispos; 1995 May; 23(5):573-6. PubMed ID: 7587933
[TBL] [Abstract][Full Text] [Related]
3. Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to
Vieira JL; Ferreira MES; Ferreira MVD; Gomes MM
Am J Trop Med Hyg; 2017 May; 96(5):1171-1175. PubMed ID: 28440745
[TBL] [Abstract][Full Text] [Related]
4. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
[TBL] [Abstract][Full Text] [Related]
5. Lack of sex effect on the pharmacokinetics of primaquine.
Elmes NJ; Bennett SM; Abdalla H; Carthew TL; Edstein MD
Am J Trop Med Hyg; 2006 Jun; 74(6):951-2. PubMed ID: 16760502
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous modeling of the pharmacokinetics and methemoglobin pharmacodynamics of an 8-aminoquinoline candidate antimalarial (WR 238605).
Brueckner RP; Fleckenstein L
Pharm Res; 1991 Dec; 8(12):1505-10. PubMed ID: 1808614
[TBL] [Abstract][Full Text] [Related]
7. Toxicity in rhesus monkeys following administration of the 8-aminoquinoline 8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline (WR242511).
Rockwood G; Duniho S; Briscoe C; Gold M; Armstrong K; Kahler D; Moran A; Baskin S
J Med Toxicol; 2008 Sep; 4(3):157-66. PubMed ID: 18821488
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R
J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria.
Kim YR; Kuh HJ; Kim MY; Kim YS; Chung WC; Kim SI; Kang MW
Arch Pharm Res; 2004 May; 27(5):576-80. PubMed ID: 15202566
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of a primaquine prodrug without red blood cell membrane destabilization property.
Davanço MG; Campos ML; Nogueira MA; Campos SL; Marques RV; dos Santos JL; Chin CM; da Fonseca LM; Peccinini RG
Biopharm Drug Dispos; 2012 Nov; 33(8):437-45. PubMed ID: 22899089
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study on hemolytic toxicity of trifluoroacetoprimaquine and primaquine in rabbits].
Shi X; Zhan C; Ha S; Yiao J
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1994; 12(3):218-20. PubMed ID: 7867160
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
[TBL] [Abstract][Full Text] [Related]
14. Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate--JPC2056--in cynomolgus monkeys using an in vivo in vitro model.
Edstein MD; Kotecka BM; Ager AL; Smith KS; DiTusa CA; Diaz DS; Kyle DE; Schiehser GA; Jacobus DP; Rieckmann KH; O'Neil MT
J Antimicrob Chemother; 2007 Oct; 60(4):811-8. PubMed ID: 17646199
[TBL] [Abstract][Full Text] [Related]
15. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
Carmona-Fonseca J; Alvarez G; Maestre A
Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
[TBL] [Abstract][Full Text] [Related]
17. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine.
Singh KK; Vingkar SK
Int J Pharm; 2008 Jan; 347(1-2):136-43. PubMed ID: 17709216
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
19. Methemoglobin formation resulting from administration of candidate 8-aminoquinoline antiparasitic drugs in the dog.
Anders JC; Chung H; Theoharides AD
Fundam Appl Toxicol; 1988 Feb; 10(2):270-5. PubMed ID: 3356313
[TBL] [Abstract][Full Text] [Related]
20. Analysis and pharmacokinetics of bulaquine and its major metabolite primaquine in rabbits using an LC-UV method--a pilot study.
Lal J; Mehrotra N; Gupta RC
J Pharm Biomed Anal; 2003 Apr; 32(1):141-50. PubMed ID: 12852456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
